Vyome 

$2.23
0
+$0.24+12.06% Today

Statistics

Day High
2.23
Day Low
2.11
52W High
-
52W Low
-
Volume
1,103
Avg. Volume
-
Mkt Cap
12.59M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

26MayExpected
Q3 2025
Q4 2025
Next
-3.12
-2.12
-1.11
-0.11
Expected EPS
-0.18
Actual EPS
N/A

Financials

-89.06%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
16.01MRevenue
-14.26MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HIND.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic offers products in the obesity and metabolic health sector, directly competing with ReShape's weight loss solutions.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its subsidiary Ethicon, provides bariatric surgery products that compete with ReShape's offerings.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation competes in the market for minimally invasive medical devices, including those for weight loss and metabolic health.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers various medical devices and nutritional products that can be seen as alternatives to weight loss surgeries.
Penumbra
PEN
Mkt Cap8.87B
Penumbra, Inc. focuses on innovative medical devices, potentially entering into or competing in the obesity management space.
Sensus Healthcare
SRTS
Mkt Cap52.44M
Sensus Healthcare, Inc. specializes in non-invasive treatments and could expand into non-surgical weight loss solutions.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, Inc. provides robotic-assisted surgical systems that can be used in bariatric surgery, competing with ReShape's solutions.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences Corporation is involved in patient-focused medical innovations, which could include obesity management solutions.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation, a medical technology company, has the potential to offer products that compete in the obesity and metabolic health sector.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but has the potential to venture into obesity management solutions.

About

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.
Show more...
CEO
ISIN
US92943X1046

Listings

0 Comments

Share your thoughts

FAQ

What is Vyome stock price today?
The current price of HIND.BOATS is $2.23 USD — it has increased by +12.06% in the past 24 hours. Watch Vyome stock price performance more closely on the chart.
What is Vyome stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Vyome stocks are traded under the ticker HIND.BOATS.
What is Vyome market cap?
Today Vyome has the market capitalization of 12.59M
When is the next Vyome earnings date?
Vyome is going to release the next earnings report on May 26, 2026.
What were Vyome earnings last quarter?
HIND.BOATS earnings for the last quarter are -0.47 USD per share, whereas the estimation was -0.47 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Vyome revenue for the last year?
Vyome revenue for the last year amounts to 16.01M USD.
What is Vyome net income for the last year?
HIND.BOATS net income for the last year is -14.26M USD.
When did Vyome complete a stock split?
The last stock split for Vyome was on August 15, 2025 with a ratio of 1:4.